EUVIMEDEUVIMED entdecken
Fallbericht

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV)

Yaddanapudi Ravindranath iD, Douglas B Craig iD, Prahlad Parajuli iD, Shruti Bagla iD, Ali Saad iD, Daniela Cukovic, Markku Heikinheimo iD, Jonna Salonen, Katherine Regling iD, Alan Dombkowski iD, Tony DeFalco iD, James J Bieker iD

British Journal of Haematology · 2026

DOI: 10.1111/bjh.70760 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Yaddanapudi Ravindranath und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wayne State University School of Medicine, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Anemia, Dyserythropoietic, Congenital, Disorder of Sex Development, 46,XY, Fibroblast Growth Factor 9, Hyaluronan Receptors. Die Arbeit nennt 60 Literaturangaben. Gefördert von: NIDDK NIH HHS, Georgie Ginopolis Chair Award (Wayne State University and Children's Foundation of Michigan), NIH (USA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A heterozygous Kruppel‐like factor 1 (KLF1) E325K mutation causes a severe form of congenital dyserythropoietic anaemia (CDA), designated CDA‐IV (Online Mendelian Inheritence in Man, OMIM 613673), a rare disease with only 15 cases known. In addition to haemolytic anaemia, manifest often at birth, four of seven (57%) of 46,XY children with KLF1 E325K mutation exhibit a range of dysmorphic external genitalia including 46,XY complete sex reversal (2/7 or 28.5%). No genital abnormalities were reported in a boy with double heterozygous KLF1 null mutations, suggesting that the KLF1 E325K variant causes, in addition to its negative impacts on erythroid differentiation, disruptions in male sex differentiation. Our studies suggest a role for a cooperative effect of concurrent ‘non‐pathogenic’ polymorphisms in multiple genes associated with disorders of sex differentiation (DSD), notably fibroblast growth factor 9 ( FGF9 ), whose expression was decreased in the gonads and peripheral blood in the case described here. We propose that the combined loss of FGF9 and CD44 (a target for CDA‐IV KLF1) resulted FGF9 signalling loss and likely caused 46,XY sex reversal. Our studies also suggest that whole‐blood gene expression studies in the proband/parent triad may provide critical clues in evaluating children with DSD, the cause of which remains undiagnosed in many cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Dyserythropoietic, CongenitalDisorder of Sex Development, 46,XYFibroblast Growth Factor 9Hyaluronan ReceptorsKruppel-Like Transcription FactorsFemaleHumansMaleMutationOvary

Stichwörter der Autor:innen

CD44CDA‐IVDSDFGF9KLF1 E325Ksex reversal

Substanzen

erythroid Kruppel-like factorFibroblast Growth Factor 9Hyaluronan ReceptorsKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Detroit Medical Center/Children's Hospital of Michigan, Detroit, Michigan, USA.
  • Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA.

ORCID-Profile: Yaddanapudi Ravindranath, Douglas B Craig, Prahlad Parajuli, Shruti Bagla, Ali Saad, Markku Heikinheimo, Katherine Regling, Alan Dombkowski, Tony DeFalco, James J Bieker

Förderung

  • NIDDK NIH HHS
  • Georgie Ginopolis Chair Award (Wayne State University and Children's Foundation of Michigan)
  • NIH (USA)
  • The Sigrid Jusélius Foundation

Zitieren

APA

Ravindranath, Y., Craig, D. B., Parajuli, P., Bagla, S., Saad, A., Cukovic, D., Heikinheimo, M., Salonen, J., Regling, K., Dombkowski, A., DeFalco, T., & Bieker, J. J. (2026). Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV). British Journal of Haematology. https://doi.org/10.1111/bjh.70760

Vancouver

Ravindranath Y, Craig DB, Parajuli P, Bagla S, Saad A, Cukovic D, et al. Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV). British Journal of Haematology. 2026. doi:10.1111/bjh.70760

BibTeX
@article{Ravindranath2026,
  author = {Ravindranath, Yaddanapudi and Craig, Douglas B and Parajuli, Prahlad and Bagla, Shruti and Saad, Ali and Cukovic, Daniela and Heikinheimo, Markku and Salonen, Jonna and Regling, Katherine and Dombkowski, Alan and DeFalco, Tony and Bieker, James J},
  title = {Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV)},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70760}
}
Kostenlos starten →